The UK publicly funded health care system will no longer allow the use of puberty blockers for children except for clinical trials.
“The NHS will only commission puberty-suppressing hormones as part of clinical research,” the National Health Service (NHS) stated in a June 9 update about implementing advice from the Cass Review, an independent review of gender identity services for children and young people.





